With over 30,000 providers of localization in the world, finding a unique position and proposition in this crowded space is a challenge for all LSPs. In 2014, Conversis went through a major restructure and rebranding which sought to align its brand to the verticals it served. This involved an analysis of market needs, honest evaluation of the value proposition, and a new strategic plan, culminating in the launch of three new businesses. In this session, Dr. Mark Hooper, leader of the new Conversis Medical, exposes what worked and what didn't during this process.
Dr Mark Hooper is responsible for the overall direction of Conversis Medical. With extensive experience in both business development and project delivery in the pharmaceutical and CRO/CMO market, Mark brings in-depth understanding of the scientific, regulatory and time-pressured nature of projects in drug development and clinical trials. Mark has worked in the pharmaceutical services field for the past 13 years, after receiving his BSc and D.Phil. at Oxford University, completing post-doctoral studies at Yale University and an MBA at Warwick University.